Patient Inquiry Information
STELLAR Brain Cancer Clinical Trial
Brain Cancer Clinical Trial: Enrollment is Now Open for Patients with Recurrent Anaplastic Astrocytoma
The STELLAR study is an investigational Phase 3 clinical trial for patients who have recurrent anaplastic astrocytoma.
A patient may qualify for this study if the patient:
· Has anaplastic astrocytoma that has recurred following radiation therapy and adjuvant temozolomide chemotherapy
· Has had prior surgery, radiation and temozolomide chemotherapy
· Is an adult over the age of 18 years old
Currently, this study is being offered at select sites in the United States, Germany and Italy. Please complete this form and a representative from an active clinical site will be in touch with you as soon as possible.
Eflornithine is an investigational product. An investigational product is one that has not been proven to be safe and effective for this use and is not licensed by the US Food and Drug Administration or any other government agency. An investigational product can only be administered in a research study.
* required information
Below are links for additional patient information:
www.abta. org (American Brain Tumor Association)
theibta.o rg (International Brain Tumor Society)
http://br aintumor.org/ (National Brain Tumor Society)
raredisea ses.org (National Organization of Rare Disorders)
Public Facebook pages:
BrainCancerMoonshot https://www.facebook. com/groups/1202877546407969/
Hope for Grey Matters https://www. facebook.com/ HopeForGreyMatters/
Private Facebook pages:
Astrocytoma Brain Cancer https://www. facebook.com/search/top/?q= astrocytoma%20brain%20cancer
Anaplastic Astrocytoma https:// www.facebook.com/search/top/? q=anaplastic%20astrocytoma% 20brain%20cancer
Braintrust.o rg http://braintrust. org/